Global Artificial Intelligence For Drug Development and Discovery 麻豆原创 Research Report 2023

Publication ID:

PB503235331

Publication Date:

March 10, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Highlights
The global Artificial Intelligence For Drug Development and Discovery market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Artificial Intelligence For Drug Development and Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Artificial Intelligence For Drug Development and Discovery is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Artificial Intelligence For Drug Development and Discovery in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Artificial Intelligence For Drug Development and Discovery include Alphabet, Atomwise, Benevolent AI, Cloud Pharmaceutical, Deep Genomics, Exscientia, IBM Corporation, Insilico Medicine and Microsoft Corporation, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence For Drug Development and Discovery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence For Drug Development and Discovery.
The Artificial Intelligence For Drug Development and Discovery market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Intelligence For Drug Development and Discovery market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence For Drug Development and Discovery companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Alphabet
Atomwise
Benevolent AI
Cloud Pharmaceutical
Deep Genomics
Exscientia
IBM Corporation
Insilico Medicine
Microsoft Corporation
Nvidia Corporation
Segment by Type
Target Identification
Molecule Screening
De Novo Drug Design & Drug Optimization
Preclinical & Clinical Testing
Segment by Application
Pharmaceutical & Biotechnology Companies
Contract Research Organization
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence For Drug Development and Discovery companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Target Identification
1.2.3 Molecule Screening
1.2.4 De Novo Drug Design & Drug Optimization
1.2.5 Preclinical & Clinical Testing
1.3 麻豆原创 by Application
1.3.1 Global Artificial Intelligence For Drug Development and Discovery 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Contract Research Organization
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence For Drug Development and Discovery 麻豆原创 Perspective (2018-2029)
2.2 Artificial Intelligence For Drug Development and Discovery Growth Trends by Region
2.2.1 Global Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence For Drug Development and Discovery Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Artificial Intelligence For Drug Development and Discovery Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Artificial Intelligence For Drug Development and Discovery 麻豆原创 Dynamics
2.3.1 Artificial Intelligence For Drug Development and Discovery Industry Trends
2.3.2 Artificial Intelligence For Drug Development and Discovery 麻豆原创 Drivers
2.3.3 Artificial Intelligence For Drug Development and Discovery 麻豆原创 Challenges
2.3.4 Artificial Intelligence For Drug Development and Discovery 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence For Drug Development and Discovery Players by Revenue
3.1.1 Global Top Artificial Intelligence For Drug Development and Discovery Players by Revenue (2018-2023)
3.1.2 Global Artificial Intelligence For Drug Development and Discovery Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Artificial Intelligence For Drug Development and Discovery 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence For Drug Development and Discovery Revenue
3.4 Global Artificial Intelligence For Drug Development and Discovery 麻豆原创 Concentration Ratio
3.4.1 Global Artificial Intelligence For Drug Development and Discovery 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence For Drug Development and Discovery Revenue in 2022
3.5 Artificial Intelligence For Drug Development and Discovery Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence For Drug Development and Discovery Product Solution and Service
3.7 Date of Enter into Artificial Intelligence For Drug Development and Discovery 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence For Drug Development and Discovery Breakdown Data by Type
4.1 Global Artificial Intelligence For Drug Development and Discovery Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Artificial Intelligence For Drug Development and Discovery Forecasted 麻豆原创 Size by Type (2024-2029)
5 Artificial Intelligence For Drug Development and Discovery Breakdown Data by Application
5.1 Global Artificial Intelligence For Drug Development and Discovery Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Artificial Intelligence For Drug Development and Discovery Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size (2018-2029)
6.2 North America Artificial Intelligence For Drug Development and Discovery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Country (2018-2023)
6.4 North America Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size (2018-2029)
7.2 Europe Artificial Intelligence For Drug Development and Discovery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Country (2018-2023)
7.4 Europe Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Artificial Intelligence For Drug Development and Discovery 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size (2018-2029)
9.2 Latin America Artificial Intelligence For Drug Development and Discovery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Artificial Intelligence For Drug Development and Discovery 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Intelligence For Drug Development and Discovery 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alphabet
11.1.1 Alphabet Company Detail
11.1.2 Alphabet Business Overview
11.1.3 Alphabet Artificial Intelligence For Drug Development and Discovery Introduction
11.1.4 Alphabet Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.1.5 Alphabet Recent Development
11.2 Atomwise
11.2.1 Atomwise Company Detail
11.2.2 Atomwise Business Overview
11.2.3 Atomwise Artificial Intelligence For Drug Development and Discovery Introduction
11.2.4 Atomwise Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.2.5 Atomwise Recent Development
11.3 Benevolent AI
11.3.1 Benevolent AI Company Detail
11.3.2 Benevolent AI Business Overview
11.3.3 Benevolent AI Artificial Intelligence For Drug Development and Discovery Introduction
11.3.4 Benevolent AI Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.3.5 Benevolent AI Recent Development
11.4 Cloud Pharmaceutical
11.4.1 Cloud Pharmaceutical Company Detail
11.4.2 Cloud Pharmaceutical Business Overview
11.4.3 Cloud Pharmaceutical Artificial Intelligence For Drug Development and Discovery Introduction
11.4.4 Cloud Pharmaceutical Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.4.5 Cloud Pharmaceutical Recent Development
11.5 Deep Genomics
11.5.1 Deep Genomics Company Detail
11.5.2 Deep Genomics Business Overview
11.5.3 Deep Genomics Artificial Intelligence For Drug Development and Discovery Introduction
11.5.4 Deep Genomics Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.5.5 Deep Genomics Recent Development
11.6 Exscientia
11.6.1 Exscientia Company Detail
11.6.2 Exscientia Business Overview
11.6.3 Exscientia Artificial Intelligence For Drug Development and Discovery Introduction
11.6.4 Exscientia Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.6.5 Exscientia Recent Development
11.7 IBM Corporation
11.7.1 IBM Corporation Company Detail
11.7.2 IBM Corporation Business Overview
11.7.3 IBM Corporation Artificial Intelligence For Drug Development and Discovery Introduction
11.7.4 IBM Corporation Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.7.5 IBM Corporation Recent Development
11.8 Insilico Medicine
11.8.1 Insilico Medicine Company Detail
11.8.2 Insilico Medicine Business Overview
11.8.3 Insilico Medicine Artificial Intelligence For Drug Development and Discovery Introduction
11.8.4 Insilico Medicine Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.8.5 Insilico Medicine Recent Development
11.9 Microsoft Corporation
11.9.1 Microsoft Corporation Company Detail
11.9.2 Microsoft Corporation Business Overview
11.9.3 Microsoft Corporation Artificial Intelligence For Drug Development and Discovery Introduction
11.9.4 Microsoft Corporation Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.9.5 Microsoft Corporation Recent Development
11.10 Nvidia Corporation
11.10.1 Nvidia Corporation Company Detail
11.10.2 Nvidia Corporation Business Overview
11.10.3 Nvidia Corporation Artificial Intelligence For Drug Development and Discovery Introduction
11.10.4 Nvidia Corporation Revenue in Artificial Intelligence For Drug Development and Discovery Business (2018-2023)
11.10.5 Nvidia Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Alphabet
Atomwise
Benevolent AI
Cloud Pharmaceutical
Deep Genomics
Exscientia
IBM Corporation
Insilico Medicine
Microsoft Corporation
Nvidia Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.